Characterization of a dual-tropic Human immunodeficiency virus (HIV-1) strain derived from the prototypical X4 isolate HXBc2

Virology

Volumn 438, Issue 1, 2013, Pages 5-13

  Xiang, Shi hua ^a,b   Pacheco, Beatriz ^a   Bowder, Dane ^b   Yuan, Wen ^a   Sodroski, Joseph ^a,c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d MIT and Harvard   (United States)

Author keywords

CCR5; Chemokine receptor; CXCR4; Entry; Envelope glycoproteins; Gp120; HIV 1; Trimer; Tropism; V3 loop

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; GLYCOPROTEIN GP 120;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RECEPTOR BINDING; STABLE EXPRESSION; VIRAL TROPISM; VIRUS ISOLATION; VIRUS MUTANT; VIRUS STRAIN;

HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MUTANT PROTEINS; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECEPTORS, HIV; VIRAL TROPISM;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84875274042     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.01.002     Document Type: Article

References (60)

1. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272(5270):1955-1958.
2. Berger E.A., Doms R.W., Fenyo E.M., Korber B.T., Littman D.R., Moore J.P., Sattentau Q.J., Schuitemaker H., Sodroski J., Weiss R.A. A new classification for HIV-1. Nature 1998, 391(6664):240.
3. Cardozo T., Kimura T., Philpott S., Weiser B., Burger H., Zolla-Pazner S. Structural basis for coreceptor selectivity by the HIV type 1 V3 loop. AIDS Res. Hum. Retroviruses 2007, 23(3):415-426.
4. Cavacini L., Duval M., Song L., Sangster R., Xiang S.H., Sodroski J., Posner M. Conformational changes in env oligomer induced by an antibody dependent on the V3 loop base. AIDS 2003, 17(5):685-689.
5. Chabot D.J., Broder C.C. Substitutions in a homologous region of extracellular loop 2 of CXCR4 and CCR5 alter coreceptor activities for HIV-1 membrane fusion and virus entry. J. Biol. Chem. 2000, 275(31):23774-23782.
6. Chan D.C., Fass D., Berger J.M., Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997, 89(2):263-273.
7. Chavda S.C., Griffin P., Han-Liu Z., Keys B., Vekony M.A., Cann A.J. Molecular determinants of the V3 loop of human immunodeficiency virus type 1 glycoprotein gp120 responsible for controlling cell tropism. J. Gen. Virol. 1994, 75(Pt 11):3249-3253.
8. Chesebro B., Wehrly K., Nishio J., Perryman S. Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. J. Virol. 1996, 70(12):9055-9059.
9. Choe H., Martin K.A., Farzan M., Sodroski J., Gerard N.P., Gerard C. Structural interactions between chemokine receptors, gp120 Env and CD4. Semin. Immunol. 1998, 10(3):249-257.
10. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P.D., Wu L., Mackay C.R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85(7):1135-1148.
11. Choe H., Li W., Wright P.L., Vasilieva N., Venturi M., Huang C.C., Grundner C., Dorfman T., Zwick M.B., Wang L., Rosenberg E.S., Kwong P.D., Burton D.R., Robinson J.E., Sodroski J.G., Farzan M. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell 2003, 114(2):161-170.
12. Chueca N., Garrido C., Alvarez M., Poveda E., de Dios Luna J., Zahonero N., Hernandez-Quero J., Soriano V., Maroto C., de Mendoza C., Garcia F. Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools. J. Med. Virol. 2009, 81(5):763-767.
13. de Jong J.J., Goudsmit J., Keulen W., Klaver B., Krone W., Tersmette M., de Ronde A. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J. Virol. 1992, 66(2):757-765.
14. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381(6584):661-666.
15. Doranz B.J., Rucker J., Yi Y., Smyth R.J., Samson M., Peiper S.C., Parmentier M., Collman R.G., Doms R.W. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996, 85(7):1149-1158.
16. Dorfman T., Moore M.J., Guth A.C., Choe H., Farzan M. A tyrosine-sulfated peptide derived from the heavy-chain CDR3 region of an HIV-1-neutralizing antibody binds gp120 and inhibits HIV-1 infection. J. Biol. Chem. 2006, 281(39):28529-28535.
17. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381(6584):667-673.
18. Farzan M., Choe H., Desjardins E., Sun Y., Kuhn J., Cao J., Archambault D., Kolchinsky P., Koch M., Wyatt R., Sodroski J. Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain. J. Virol. 1998, 72(9):7620-7625.
19. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272(5263):872-877.
20. Foda M., Harada S., Maeda Y. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity. Microbiol. Immunol. 2001, 45(7):521-530.
21. Fouchier R.A., Brouwer M., Broersen S.M., Schuitemaker H. Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR. J. Clin. Microbiol. 1995, 33(4):906-911.
22. Hartley O., Klasse P.J., Sattentau Q.J., Moore J.P. V3: HIV's switch-hitter. AIDS Res. Hum. Retroviruses 2005, 21(2):171-189.
23. Helseth E., Olshevsky U., Furman C., Sodroski J. Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein. J. Virol. 1991, 65(4):2119-2123.
24. Helseth E., Olshevsky U., Gabuzda D., Ardman B., Haseltine W., Sodroski J. Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion. J. Virol. 1990, 64(12):6314-6318.
25. Hoffman N.G., Seillier-Moiseiwitsch F., Ahn J., Walker J.M., Swanstrom R. Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop. J. Virol. 2002, 76(8):3852-3864.
26. Hoffman T.L., Doms R.W. HIV-1 envelope determinants for cell tropism and chemokine receptor use. Mol. Membr. Biol. 1999, 16(1):57-65.
27. Holland A.U., Munk C., Lucero G.R., Nguyen L.D., Landau N.R. Alpha-complementation assay for HIV envelope glycoprotein-mediated fusion. Virology 2004, 319(2):343-352.
28. Huang C.C., Lam S.N., Acharya P., Tang M., Xiang S.H., Hussan S.S., Stanfield R.L., Robinson J., Sodroski J., Wilson I.A., Wyatt R., Bewley C.A., Kwong P.D. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 2007, 317(5846):1930-1934.
29. Huang C.C., Tang M., Zhang M.Y., Majeed S., Montabana E., Stanfield R.L., Dimitrov D.S., Korber B., Sodroski J., Wilson I.A., Wyatt R., Kwong P.D. Structure of a V3-containing HIV-1 gp120 core. Science 2005, 310(5750):1025-1028.
30. Hung C.S., Vander Heyden N., Ratner L. Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization. J. Virol. 1999, 73(10):8216-8226.
31. Hwang S.S., Boyle T.J., Lyerly H.K., Cullen B.R. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991, 253(5015):71-74.
32. Jensen M.A., Li F.S., van't Wout A.B., Nickle D.C., Shriner D., He H.X., McLaughlin S., Shankarappa R., Margolick J.B., Mullins J.I. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J. Virol. 2003, 77(24):13376-13388.
33. Korber, B.T., Foley, B.T., Kuiken, C.L., Pillai, S.K., Sodroski, J.G., 1998. Numbering positions in HIV relative to HXBc2. In: Human Retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, New Mexico.
34. Low A.J., Dong W., Chan D., Sing T., Swanstrom R., Jensen M., Pillai S., Good B., Harrigan P.R. Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates. AIDS 2007, 21(14):F17-F24.
35. Maeda Y., Yusa K., Harada S. Altered sensitivity of an R5X4 HIV-1 strain 89.6 to coreceptor inhibitors by a single amino acid substitution in the V3 region of gp120. Antivir. Res. 2008, 77(2):128-135.
36. Maeda K., Das D., Yin P.D., Tsuchiya K., Ogata-Aoki H., Nakata H., Norman R.B., Hackney L.A., Takaoka Y., Mitsuya H. Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition. J. Mol. Biol. 2008, 381(4):956-974.
37. Mao Y., Wang L., Gu C., Herschhorn A., Xiang S.H., Haim H., Yang X., Sodroski J. Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimer. Nat. Struct. Mol. Biol. 2012, 19(9):893-899.
38. Ogert R.A., Lee M.K., Ross W., Buckler-White A., Martin M.A., Cho M.W. N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J. Virol. 2001, 75(13):5998-6006.
39. Pacheco B., Basmaciogullari S., Labonte J.A., Xiang S.H., Sodroski J. Adaptation of the human immunodeficiency virus type 1 envelope glycoproteins to new world monkey receptors. J. Virol. 2008, 82(1):346-357.
40. Polzer S., Dittmar M.T., Schmitz H., Schreiber M. The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization. Virology 2002, 304(1):70-80.
41. Rana S., Besson G., Cook D.G., Rucker J., Smyth R.J., Yi Y., Turner J.D., Guo H.H., Du J.G., Peiper S.C., Lavi E., Samson M., Libert F., Liesnard C., Vassart G., Doms R.W., Parmentier M., Collman R.G. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation. J. Virol. 1997, 71(4):3219-3227.
42. Rho H.M., Poiesz B., Ruscetti F.W., Gallo R.C. Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line. Virology 1981, 112(1):355-360.
43. Samson M., LaRosa G., Libert F., Paindavoine P., Detheux M., Vassart G., Parmentier M. The second extracellular loop of CCR5 is the major determinant of ligand specificity. J. Biol. Chem. 1997, 272(40):24934-24941.
44. Sander O., Sing T., Sommer I., Low A.J., Cheung P.K., Harrigan P.R., Lengauer T., Domingues F.S. Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage. PLoS Comput. Biol. 2007, 3(3):e58.
45. Schnur E., Noah E., Ayzenshtat I., Sargsyan H., Inui T., Ding F.X., Arshava B., Sagi Y., Kessler N., Levy R., Scherf T., Naider F., Anglister J. The conformation and orientation of a 27-residue CCR5 peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide. J. Mol. Biol. 2011, 410(5):778-797.
46. Shioda T., Levy J.A., Cheng-Mayer C. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 1992, 89(20):9434-9438.
47. Sullivan N., Sun Y., Li J., Hofmann W., Sodroski J. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 1995, 69(7):4413-4422.
48. Svicher, V., Alteri, C., Artese, A., Zhang, J.M., Costa, G., Mercurio, F., D'Arrigo, R., Alcaro, S., Palu, G., Clementi, M., Zazzi, M., Andreoni, M., Antinori, A., Lazzarin, A., Ceccherini-Silberstein, F., Perno, C.F. Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage. Antivir. Ther. 16 (7), 1035-1045.
49. Verrier F., Borman A.M., Brand D., Girard M. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage. AIDS Res. Hum. Retroviruses 1999, 15(8):731-743.
50. Weissenhorn W., Dessen A., Harrison S.C., Skehel J.J., Wiley D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 1997, 387(6631):426-430.
51. Willey R.L., Theodore T.S., Martin M.A. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope. J. Virol. 1994, 68(7):4409-4419.
52. Wu L., Gerard N.P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A.A., Desjardin E., Newman W., Gerard C., Sodroski J. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 1996, 384(6605):179-183.
53. Wu L., LaRosa G., Kassam N., Gordon C.J., Heath H., Ruffing N., Chen H., Humblias J., Samson M., Parmentier M., Moore J.P., Mackay C.R. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. 1997, 186(8):1373-1381.
54. Wyatt R., Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 1998, 280(5371):1884-1888.
55. Xiang S.H., Farzan M., Si Z., Madani N., Wang L., Rosenberg E., Robinson J., Sodroski J. Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody. J. Virol. 2005, 79(10):6068-6077.
56. Xiang S.H., Finzi A., Pacheco B., Alexander K., Yuan W., Rizzuto C., Huang C.C., Kwong P.D., Sodroski J. A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer. J. Virol. 2010, 84(7):3147-3161.
57. Xiang S.H., Wang L., Abreu M., Huang C.C., Kwong P.D., Rosenberg E., Robinson J.E., Sodroski J. Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains. Virology 2003, 315(1):124-134.
58. Xiao L., Owen S.M., Goldman I., Lal A.A., deJong J.J., Goudsmit J., Lal R.B. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology 1998, 240(1):83-92.
59. Zhang J., Rao E., Dioszegi M., Kondru R., DeRosier A., Chan E., Schwoerer S., Cammack N., Brandt M., Sankuratri S., Ji C. The second extracellular loop of CCR5 contains the dominant epitopes for highly potent anti-human immunodeficiency virus monoclonal antibodies. Antimicrob. Agents Chemother. 2007, 51(4):1386-1397.
60. Zhu P., Chertova E., Bess J., Lifson J.D., Arthur L.O., Liu J., Taylor K.A., Roux K.H. Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions. Proc. Natl. Acad. Sci. USA 2003, 100(26):15812-15817.